Table 1.
Clinicopathologic features of sporadic and probable Lynch Syndrome-associated endometrial cancers.
Clinical Features | Sporadic EC1 N (%) |
PLS EC2 N (%) |
p -value |
---|---|---|---|
| |||
Median Age at Diagnosis (yrs) Range |
61 (18–92) | 61 (42–87) | |
| |||
Age (yrs) | |||
< 50 | 52 (14.2) | 10 (23.3) | 0.12 |
≥ 50 | 313 (85.8) | 33 (76.7) | |
| |||
BMI (kg/m2) | |||
< 30 | 121 (33.2) | 17 (39.5) | 0.41 |
≥ 30 | 243 (66.8) | 26 (60.5) | |
| |||
History of Diabetes | |||
Y | 89 (24.4) | 9 (20.9) | 0.62 |
N | 276 (75.6) | 34 (79.1) | |
| |||
History of Hypertension | |||
Y | 201 (55.1) | 18 (41.9) | 0.10 |
N | 164 (44.9) | 25 (58.1) | |
| |||
3 Family History of EC | |||
Y | 35 (9.8) | 4 (9.8) | > 0.99 |
N | 323 (90.2) | 37 (90.2) | |
| |||
3 Family History of CRC4 | |||
Y | 58 (16.2) | 8 (19.0) | 0.63 |
N | 301 (83.8) | 34 (81.) | |
| |||
Family History of CRC or EC | |||
Y | 87 (24.2) | 12 (28.6) | 0.54 |
N | 272 (75.8) | 30 (71.4) |
Pathologic Features | Sporadic EC N (%) |
PLS EC N (%) |
p -value |
---|---|---|---|
| |||
Histology | |||
Endometrioid | 299 (81.9) | 37 (86.0) | 0.67 |
Non-endometrioid | 66 (18.1) | 6 (14.0) | |
| |||
FIGO5 Stage | |||
I & II | 289 (79.2) | 37 (86.0) | 0.42 |
III & IV | 76 (20.8) | 6 (14.0) | |
| |||
FIGO Grade | |||
1 & 2 | 267 (73.2) | 32 (74.4) | 0.86 |
3 | 98 (26.8) | 11 (25.6) | |
| |||
Depth of myometrial invasion | |||
< 50% | 257 (70.4) | 32 (74.4) | 0.58 |
≥ 50% | 108 (29.6) | 11 (25.6) | |
| |||
Tumor Location | |||
Corpus | 357 (97.8) | 38 (88.4) | 0.007 |
Lower uterine segment | 8 (2.2) | 5 (11.6) | |
| |||
Largest gross tumor dimension (cm) | |||
Mean ± Standard Deviation | 4.3 ± 3.2 | 3.6 ± 2.9 | 0.13 |
Median (range)6 | 4 (0–25) | 3.5 (0–13) |
EC; Endometrial Cancer
PLS EC; Probable Lynch Syndrome-associated endometrial cancer
Family history of EC or CRC; patient has a first- or second-degree relative with a diagnosis of endometrial cancer or colorectal cancer
CRC; Colorectal cancer
FIGO; International Federation of Gynecology and Obstetrics
Some tumors were not apparent grossly, but were identified by microscopic examination of the entire endometrium. These tumors were designated with a largest gross tumor dimension of 0.